Brief: Cytek Biosciences Reports Third Quarter 2022 Financial Results
Cytek Biosciences Inc CTKB.O :
* CYTEK BIOSCIENCES REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
* CYTEK BIOSCIENCES INC Q3 REVENUE ROSE 18 PERCENT TO $40.5
MILLION
* CYTEK BIOSCIENCES INC- TOTAL REVENUE $40.5 MILLION FOR Q3,
UP
18%
* CYTEK BIOSCIENCES INC- CONTINUES TO EXPECT FY 2022 REVENUE
TO BE
CLOSER TO HIGH END OF RANGE OF $160 MILLION TO $168 MILLION
* CYTEK BIOSCIENCES INC- QTRLY EARNINGS PER SHARE$0.01
Source text for Eikon: ID:nGNX1D8gZp
Further company coverage: CTKB.O
Recent news on Cytek Biosciences
See all newsCytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says (updated)
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says
Cytek Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cytek Biosciences Q2 revenue slightly misses estimates
Brief: Cytek Biosciences Q2 Revenue USD 48.14 Million